SCHEMBL2500404

SCHEMBL2500404

O=C(Cc1ccc(S(=O)(=O)c2ccc(CC(=O)c3ccccc3)cc2)cc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 2/20 0.54
MAPT P10636 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
PLAU P00749 1/20 0.53
SRD5A2 P31213 2/20 0.51
STS P08842 1/20 0.51
HTR6 P50406 2/20 0.49
MEN1 O00255 2/20 0.47
HPGD P15428 2/20 0.47
KMT2A Q03164 2/20 0.47
RECQL P46063 1/20 0.47
HSD11B1 P28845 1/20 0.47
CES1 P23141 2/20 0.47
CES2 O00748 1/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11033528 0.87 SMN1; SMN2 (0.52) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL7199268 0.86 MAPT (0.67) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL6026005 0.86 MAPT (0.54) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL6341279 0.86 PTGS2 (0.51) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL6026667 0.86 CA1 (0.61) PLAUSTSKMT2AKDM4ESMN1; SMN2
SCHEMBL4282905 0.84 MAPT (0.70) MAPTL3MBTL1PLAUSRD5A2STS
Sulfuric Acid SCHEMBL4404554 0.83 MAPT (0.59) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL24800 0.82 MAPT (0.73) MAPTL3MBTL1PLAUSRD5A2STS
SCHEMBL10529173 0.80 SMN1; SMN2 (0.57) MAPTL3MBTL1PLAUSRD5A2STS
Water SCHEMBL9243001 0.80 MAPT (0.70) MAPTL3MBTL1PLAUSRD5A2STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994022-A BECOMES SOLUBLE IN ALKALI DEVELOPING SOLUTION BY ACTION OF AN ACID JSR CORPORATION (JP) 1999-11-30 US claimed
US-10421853-B2 Photosensitive gas generating agent and photocurable composition CANON KABUSHIKI KAISHA (JP) 2019-09-24 US disclosed
EP-2941781-B1 PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION CANON KK (JP) 2017-08-09 EP disclosed
US-20150368433-A1 PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION CANON KABUSHIKI KAISHA (JP) 2015-12-24 US disclosed
EP-2941781-A1 PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION Canon Kabushiki Kaisha (JP) 2015-11-11 EP disclosed
US-20150086755-A1 PHOTOCURED PRODUCT CANON KABUSHIKI KAISHA (JP) 2015-03-26 US disclosed
WO-2014136977-A1 PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION CANON KABUSHIKI KAISHA (JP) 2014-09-12 WO disclosed
WO-2013183468-A1 PHOTOCURED PRODUCT CANON KABUSHIKI KAISHA (JP) 2013-12-12 WO disclosed
US-8582210-B2 Lens and method for producing lens CANON KABUSHIKI KAISHA (JP) 2013-11-12 US disclosed
US-20110242672-A1 LENS AND METHOD FOR PRODUCING LENS CANON KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed
WO-2000059494-A1 STYRYL SULFONE ANTICANCER AGENTS TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2000-10-12 WO disclosed
US-6114086-A COMPRISING ALKALI-SOLUBLE RESIN, DISSOLUTION CONTROLLING AGENTS, PHOTOACID GENERATOR, SOLVENT; USED FOR THE MANUFACTURE OF SEMICONDUCTOR DEVICES OR INTEGRATED CIRCUITS JSR CORPORATION (JP) 2000-09-05 US disclosed
EP-1027330-A1 STYRYL SULFONE ANTICANCER AGENTS Temple University of the Commonwealth System of Higher Education (US) 2000-08-16 EP disclosed
US-5994022-A BECOMES SOLUBLE IN ALKALI DEVELOPING SOLUTION BY ACTION OF AN ACID JSR CORPORATION (JP) 1999-11-30 US disclosed
US-5916729-A A POSITIVE TONE TYPE REISTS CONSISTS OF A RESIN WHICH HAS AN ACIDIC FUNCTIONAL GROUP PROTECTED BY AN ACID DECOMPOSABLE GROUP AND IS HYDROLYZABLE, A PHOTOACID GENERATOR AND A SOLVENT MIXTURE OF ALKYL LACTATE WITH PROPYLENE GLYCOL ETHER JSR CORPORATION (JP) 1999-06-29 US disclosed
WO-1999018068-A1 STYRYL SULFONE ANTICANCER AGENTS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1999-04-15 WO disclosed
EP-0843220-A1 Radiation sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1998-05-20 EP disclosed
EP-0634696-B1 Chemically amplified resist composition JAPAN SYNTHETIC RUBBER CO LTD (JP) 1998-01-14 EP disclosed
US-5629135-A ALKALI-SOLUBLE RESIN, CROSSLINKER, PHOTOACID GENERATOR, SOLVENT JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1997-05-13 US disclosed
EP-0634696-A1 Chemically amplified resist composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1995-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368433-A1 PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION PFN1, PFAS, FRG1 PRMT1 4551/4885MAPT 2074/4885L3MBTL1 4337/4885
US-10421853-B2 Photosensitive gas generating agent and photocurable composition PFN1, PFAS, FRG1 PRMT1 4551/4885MAPT 2074/4885L3MBTL1 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.